Hang Lung Development has invested in two new technology-related projects in Hong Kong and Shanghai, bringing its investment in non-property businesses since its diversification last year to about US$30 million.
Executive director Alfred Li Hung-kwan said the two ventures included a bio-technology research project with the University of Hong Kong and a minority stake in a semiconductor plant in Shanghai.
Mr Li said the project related to development of a cement to help mend damaged bone.
Another venture in Shanghai could help to build up the company's network in the mainland as it might become a potential customer in future, he said.
In the United States and Taiwan, the company had become involved in producing added-value materials for semiconductor plants, he said.
Mr Li said the investment in the Shanghai venture was insignificant, pointing out that the company had no plans to invest heavily in semiconductors, given it involved billions of dollars.
The company had so far invested about US$30 million in non-property projects, he said, adding it would not be hasty in making such investment decisions.
